Universitäres Krebszentrum Leipzig

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Gastric and oesophageal cancer2 trials
• Chronic lymphocytic leukaemia1 trial
• Diffuse large B-cell lymphoma1 trial
• Follicular lymphoma1 trial
• Head and neck cancer1 trial
• Mantle cell lymphoma1 trial
• Metastatic breast cancer1 trial

Phase

• Phase 1/21 trial
• Phase 21 trial
• Phase 2/31 trial
• Phase 31 trial

Status

• Completed2 trials
• Recruiting2 trials
• Terminated1 trial

Lead sponsor

• BeiGene1 trial
• BeOne Medicines1 trial
• Gilead Sciences1 trial
• Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest1 trial
• University Hospital Tuebingen1 trial

Running trials

• Recruiting

  A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

  NCT05006716· Phase 1/2· BeOne Medicines· Source

  Contact: BeOne Medicines

• Recruiting

  Praegnant Breast Cancer: Early/Advanced/Metastatic

  NCT02338167· University Hospital Tuebingen· Source

  Contact: Erik Belleville, PhD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic lymphocytic leukaemia1 recruiting
• Diffuse large B-cell lymphoma1 recruiting
• Follicular lymphoma1 recruiting
• Mantle cell lymphoma1 recruiting
• Metastatic breast cancer1 recruiting

Closed trials

• Terminated

  Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma

  NCT04854499· Phase 2· Gilead Sciences· Source

• Completed

  A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

  NCT03783442· Phase 3· BeiGene· Source

• Completed

  Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative Chemotherapy

  NCT03081143· Phase 2/3· Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest· Source